Covid-19: Pfizer could have Omicron-targeted vaccine by March, says CEO

  • World
  • Tuesday, 11 Jan 2022

NEW YORK (Reuters): Pfizer Inc chief executive Albert Bourla on Monday (Jan 10) said a redesigned Covid-19 vaccine that specifically targets the Omicron coronavirus variant is likely needed and his company could have one ready to launch by March.

Bourla said Pfizer and partner BioNTech SE are working on both an Omicron-targeted vaccine version as well as a shot that would include both the previous vaccine as well as one targeted at the fast-spreading variant.

Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Covid-19 , Omicron , Pfizer


Next In World

Pope Francis in hospital for check-up - ANSA news agency
Harry in UK court to give evidence against tabloid publisher
Prince Harry arrives at UK court for rare royal appearance
German man held for role in fatal arson attack on asylum seekers in 1991
India train crash: hurtling into loop of disaster
Sri Lanka to reduce drug prices by 16% as crisis eases- minister
Repeated arrests, filthy cells: Inside Pakistan's crackdown
Russia says no threat 'for now' to Ukraine's Zaporizhzhia nuclear plant after dam breach
Over 100 dead bodies remain unclaimed after Indian rail disaster
Indonesia braces for forest fires, crop loss from severe dry season

Others Also Read